OpenURL Connection Search

Select item for more details and to access through your institution.

Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?
Published in:
Pharmacogenomics Journal, 2005, v. 5, n. 5, p. 298, doi. 10.1038/sj.tpj.6500323
By:
- Fernø, J.;
- Raeder, M. B.;
- Vik-Mo, A. O.;
- Skrede, S.;
- Glambek, M.;
- Tronstad, K.-J.;
- Breilid, H.;
- Løvlie, R.;
- Berge, R. K.;
- Stansberg, C.;
- Steen, V. M.
Publication type:
Article
Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.
Published in:
Molecular Psychiatry, 2010, v. 15, n. 5, p. 463, doi. 10.1038/mp.2008.110
By:
- Le Hellard, S.;
- Mühleisen, T. W.;
- Djurovic, S.;
- Fernø, J.;
- Ouriaghi, Z.;
- Mattheisen, M.;
- Vasilescu, C.;
- Raeder, M. B.;
- Hansen, T.;
- Strohmaier, J.;
- Georgi, A.;
- Brockschmidt, F. F.;
- Melle, I.;
- Nenadic, I.;
- Sauer, H.;
- Rietschel, M.;
- Nöthen, M. M.;
- Werge, T.;
- Andreassen, O. A.;
- Cichon, S.
Publication type:
Article
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Published in:
Molecular Psychiatry, 2009, v. 14, n. 3, p. 308, doi. 10.1038/sj.mp.4002133
By:
- Le Hellard, S.;
- Theisen, F. M.;
- Haberhausen, M.;
- Raeder, M. B.;
- Fernø, J.;
- Gebhardt, S.;
- Hinney, A.;
- Remschmidt, H.;
- Krieg, J. C.;
- Mehler-Wex, C.;
- Nöthen, M. M.;
- Hebebrand, J.;
- Steen, V. M.
Publication type:
Article

Found: 3

Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?

Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?